GNLX Competitors & Alternatives
Compare Genelux Corporation Common Stock with similar stocks in the same industry
Biotechnology
GNLX
Main Stock$3.03
Tradestie Score
58
Market Cap
$166.20M
Revenue Growth
-1.0%
Analyst Upside
+477.6%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.34
|
$202.58M | - | 56 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$17.95
|
$199.71M | - | 49 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$14.33
|
$170.45M | - | 52 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$5.55
|
$158.43M | - | 60 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.71
|
$133.50M | - | 58 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$22.75
|
$117.07M | - | 52 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.00
|
$110.20M | - | 57 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$28.17
|
$76.55M | - | 50 | Compare |
|
EUDA
EUDA Health Holdings Limited Ordinary Shares
|
$15.20
|
$73.94M | - | 52 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.55
|
$71.69M | - | 56 | Compare |
More GNLX Analysis
Data updated: Jun 17, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry